Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

NCT00640861 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: CpG oligodeoxynucleotide
BIOLOGICAL: HER-2/neu peptide vaccine
BIOLOGICAL: MUC-1 peptide vaccine
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: sargramostim
OTHER: immunoenzyme technique
OTHER: immunologic technique

Sponsor

Mayo Clinic

Collaborators

[object Object]